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Background: AAA ATPase proteins play integral roles in the export apparatus of many bacterial organelles.
Results: The secondmessenger cyclic di-GMP binds specifically to multiple export ATPases at a highly conserved binding site.
Conclusion: Cyclic di-GMP binding is central to the function of many different bacterial export complexes.
Significance:This profoundly affects our understanding of numerous important bacterial organelles, including flagella, type III,
and type VI secretion systems.
The widespread second messenger molecule cyclic di-GMP
(cdG) regulates the transition frommotile and virulent lifestyles
to sessile, biofilm-forming ones in a wide range of bacteria.
Many pathogenic and commensal bacterial-host interactions
are known to be controlled by cdG signaling. Although the bio-
chemistry of cyclic dinucleotidemetabolism is well understood,
much remains to be discovered about the downstream signaling
pathways that induce bacterial responses upon cdG binding. As
part of our ongoing research into the role of cdG signaling in
plant-associated Pseudomonas species, we carried out an affin-
ity capture screen for cdG binding proteins in the model orga-
nism Pseudomonas fluorescens SBW25. The flagella export
AAA ATPase FliI was identified as a result of this screen and
subsequently shown to bind specifically to the cdG molecule,
with aKD in the lowmicromolar range. The interaction between
FliI and cdG appears to be very widespread. In addition to FliI
homologs from diverse bacterial species, high affinity binding was
also observed for the type III secretion system homolog HrcN and
the type VI ATPase ClpB2. The addition of cdG was shown to
inhibit FliI and HrcN ATPase activity in vitro. Finally, a combina-
tion of site-specific mutagenesis, mass spectrometry, and in silico
analysis was used to predict that cdG binds to FliI in a pocket of
highly conserved residues at the interface between two FliI sub-
units.Our results suggest anovel, fundamental role for cdG incon-
trolling the function of multiple important bacterial export path-
ways, through direct allosteric control of export ATPase proteins.
Pseudomonas fluorescens is a widespread soil bacterium that
forms commensal relationships with plant species.Members of
the P. fluorescens species group nonspecifically colonize the
rhizosphere and phyllosphere of many plants and promote
plant growth, as well as providing potent antifungal and other
biocontrol capabilities (1–3). The related bacteriumPseudomo-
nas syringae is a Gram-negative phytopathogen and is respon-
sible for numerous important plant diseases. P. syringae pro-
duces a large number of species-specific phytotoxins and type
III-secreted effectormolecules that subvert plant defenses (4, 5)
and infects host plants by migration through open stomata and
wounds on the plant surface. Two of themost important organ-
elles for efficient host colonization by both commensal and
pathogenic Pseudomonas sp. are the flagellum and the type III
secretion system (T3SS).3 Flagella-mediated motility is critical
during the initial stages both of infection and benign plant col-
onization and is required tomove through the soil toward plant
roots, to colonize plant surfaces, and to migrate into the apo-
plastic space (6). Type III secretion systems, needle-like struc-
tures that inject effector proteins into plant cells, play a critical
role in P. syringae virulence (4) and have also been shown to be
important for rhizosphere colonization by P. fluorescens (6).
Assembly of the bacterial flagellum is tightly regulated and
proceeds via the export of extracellular subunits through the
central pore of the extending complex (7–9). The AAA
ATPase FliI, together with FliH and FliJ, forms the soluble com-
ponent of the flagellar export apparatus (8, 10, 11). FliI and FliH
form a heterotrimer (FliH2-FliI) in vivo and along with FliJ
deliver export substrates from the cytoplasm to the flagellum
export gate. There, FliI forms a hexameric ring and is anchored
to the export gate by FliJ and FliH (12). Although themajority of
the energy required for flagella formation is provided by the
proton motive force, FliI ATPase activity is required for effi-
cient flagella formation and plays a role in the initiation of pro-
tein export (13, 14). The secretion apparatus of flagella and
T3SS share a conserved core architecture, with many proteins
in common including the protein export apparatus (9, 13).
* This work was supported by Institute Strategic Program Grants awarded to
the John InnesCentre (to J. G. M., R. L., C. E. M. S., andD. L.) and the Institute
for Food Research (to T. W.) and by University of East Anglia start-up fund-
ing (to J. G. M.). The authors declare that they have no conflicts of interest
with the contents of this article.
□S This article contains supplemental Fig. S1.
Author’s Choice—Final version free via Creative Commons CC-BY license.
1 Supported by a Biotechnology and Biological Sciences Research Council
Doctoral Training Partnership Ph.D. studentship.
2 To whom correspondence should be addressed. Tel.: 44-1603-450-727;
E-mail: jacob.malone@jic.ac.uk.
3 The abbreviationsusedare: T3SS, type III secretion system; SPR, surfaceplas-
mon resonance; cdG, cyclic di-GMP; DRaCALA, differential radial capillary
of ligand assay; MS-PSA, mass spectrometry peak-shift analysis.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 40, pp. 24470–24483, October 2, 2015
Author’s Choice © 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
crossmark
24470 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 40•OCTOBER 2, 2015
Investigations into the signaling pathways that control inter-
actions between pathogenic and commensal Pseudomonas sp.
and their host plants have highlighted a central role for the
bacterial second messenger cyclic di-GMP (cdG) (15–21). cdG
is a ubiquitous regulator of bacterial behavior, controlling the
transition between motility and sessility, and chronic and viru-
lent lifestyles in a wide range of bacteria. Recently, cdG has
emerged as a crucial factor in the signaling pathways of most
bacterial species, determining when, where, and how bacteria
form biofilms, progress through the cell cycle, and regulate dif-
ferent aspects of motility and virulence (22). Broadly speaking,
cdG production is associated with community behavior pheno-
types such as biofilm formation and surface attachment. Con-
versely, low cdG levels are connected to unicellular, motile, and
virulent lifestyles (22). cdG affects cell phenotypes by regulating
the expression, production, and activity of different phenotypic
output pathways. These outputs are controlled by cdG binding
to effectors that function at transcriptional (23), translational
(24), and post-translational, allosteric levels (25, 26). Individual
phenotypic outputs may be controlled at multiple regulatory
stages. For example, the expression of multiple flagella genes
are controlled by the cdG-binding transcriptional regulator
FleQ (23, 27). Flagella function is also allosterically controlled
by cdG, with binding to the basal body-associated proteins
YcgR and FlgZ leading to reduced flagella rotation speed in
Escherichia coli and Pseudomonas putida, respectively (28, 29).
cdG-mediated signaling pathways are typically highly com-
plex. Numerous species, including the pseudomonads, contain
dozens ofmetabolic enzymes and display diverse cdG-triggered
phenotypes (22). Although the synthesis and degradation of
cdG by GGDEF, EAL, and HD-GYP proteins is fairly well
understood (30–33), much remains to be discovered about the
effector proteins that bind the dinucleotide molecule and elicit
downstream responses in the cell. Although several predictable
cdG binding folds are known, for example the PilZ (34) and
degenerate GGDEF and EAL domains (35–37), cdG is a pro-
miscuousmolecule and binds to a diverse range of protein folds.
In many cases, these cdG binding motifs are impossible to
bioinformatically predict in advance (27, 38–41). This, com-
bined with the complexity of cdG signaling and the diverse
array of interconnected, cdG-associated phenotypes (22, 42,
43) suggests that a great many cdG binding proteins still await
discovery.
Recent investigations by several research groups have made
effective use of biochemical and spectrometric techniques for
the isolation and identification of cdG binding proteins (44–
46). These studies have both increased our understanding of
the phenotypes and cellular functions controlled by this second
messenger and substantially expanded the number of recog-
nized binding motifs and protein domains (40, 42, 43). To bet-
ter understand the role of cdG in the interactions between
plant-associated Pseudomonas species and their hosts, we used
a cdG capture compound assay (45) to screen for cdG binding
proteins in the model P. fluorescens strain SBW25 (47). Among
the proteins we identified in this screen was the flagella export
ATPase FliI (PFLU4436). Subsequent biochemical analysis
showed that SBW25 FliI specifically binds to cdG with a KD in
the low micromolar range. FliI-cdG binding was not confined
to P. fluorescens but was also seen for FliI homologs from sev-
eral other bacterial species, as well as the closely related T3SS
export ATPase HrcN from P. syringae (PSPTO1400) and the
significantly more divergent type VI secretion system secretion
ATPase ClpB2 (PFLU6025).
In vitro addition of cdG induced amarked, concentration-de-
pendent inhibition of ATPase activity for both FliI and HrcN.
However, the association between ATPase activity and cdG
binding is not absolute: mutation of critical active site residues
in both FliI and HrcN abolishes ATP hydrolysis, whereas dinu-
cleotide binding is unaffected. To further probe the relation-
ship between FliI and cdG, a combination ofmass spectrometry
and in silico analysis was used to predict the FliI dinucleotide
binding site. These results suggest that cdG may bind in a
pocket of highly conserved residues at the interface between
two domains of the FliI hexameric ring. Our results suggest a
fundamental new role for the signaling molecule cdG, in the
structure and function of multiple widespread and biologically
important bacterial export pathways.
Experimental Procedures
Strains and Growth Conditions—Strains and plasmids are
listed in Table 1. Primers are listed in Table 2. Unless otherwise
stated, all P. fluorescens strains were grown at 28 °C and E. coli
at 37 °C in lysogenic broth (48), solidified with 1.5% (w/v) agar
where appropriate. For protein overexpression, terrific broth
was used. Kanamycin was used at 50 g/ml, carbenicillin was
used at 100 g/ml, and chloramphenicol was used at 30 g/ml.
For inducible plasmids, isopropyl -D-thiogalactopyranoside
was added to a final concentration 0.5 mM as appropriate.
Molecular Biology Procedures—Cloning was carried out in
accordance with standard molecular biology techniques. The
TABLE 1
Strains and plasmids used in this study
Description Reference
Strains
E. coli BL21-(DE3) SmR, K12 recF143 lacIq lacZ.M15, xylA Novagen
E. coli DH5 endA1, hsdR17(rK-mK), supE44, recA1, gyrA (NalR), relA1, (lacIZYA-argF)
U169, deoR, 80dlac(lacZ)M15
Ref. 82
SBW25 Environmental P. fluorescens isolate Ref. 47
Pto DC3000 RifR derivative of P. syringae pv. Tomato NCPPB 1106 Ref. 84
Salmonella enterica pv. typhimurium Strain LT2 Ref. 51
Sinorhizobium meliloti Strain 1020 Ref. 83
Plasmids
pETNdeM-11 KmR, purification vector, N-terminal His6 tag Ref. 49
pETNdeM-11-overexpression vectors Various overexpression vectors for fliI alleles, hrcN, and clpB2 ligated between the
NdeI and EcoRI sites of pETNdeM-11
This study
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pETNdeM-11-fliI, hrcN, and clpB2 purification vectors were
produced by ligating PCR fragments (amplified with primers
A–M from appropriate genomic DNA) between the NdeI and
EcoRI sites of plasmid pETNdeM-11 (49) as appropriate. Strand
overlap extension (50) was used to produce Walker A and
Walker B mutants in FliI and HrcN using primers N–U, before
cloning into expression vectors as appropriate.
cdG Capture Compound Experiments—Experiments were
performed as described byNesper et al. (45). P. fluorescens cells
were grown in M9 0.4% (w/v) pyruvate medium  0.4% (w/v)
casamino acids to stationary phase and to mid-logarithmic
phase, lysogenic broth to stationary phase, andKings Bmedium
to logarithmic phase. Cells were collected by centrifugation for
5 min at 5,000  g. The pellet was resuspended in lysis buffer
(6.7 mM MES, 6.7 mM HEPES, pH 7.5, 200 mM NaCl, 6.7 mM
sodium acetate and 10 mM -mercaptoethanol) with protease
inhibitors andDNase I (Roche). Cells were lysed using a French
press (3  20,000 p.s.i.), and lysates were centrifuged at
100,000 g for 1 h. The supernatant was then used to identify
soluble cdG binding proteins. 600 g of the soluble protein
mixture was used and was mixed with 20 l of capture buffer
(100 mM HEPES, pH 7.5, 250 mM sodium acetate, 50 mM mag-
nesium acetate, 50% (v/v) glycerol), plus 12.5 l of 10 mM cdG
for the control samples. Volumes were adjusted to 100 l with
water, and the reactions were then incubated for 2 h at 4 °C,
before UV irradiation for 4 min using a caproBox (Caprotec
Bioanalytics, Berlin, Germany). Magnetic streptavidin beads
(50 l) were added with 25 l of 5 wash buffer (250 mM Tris,
pH 7.5, 5 M NaCl, 0.1% (w/v) n-octyl--glucopyranoside), and
the sampleswere incubated for 45min at 4 °C on a rotarywheel.
The beads were collected with a magnet, and the samples were
washed six timeswith 200l of 1wash buffer. The beadswere
resuspended in 20 l of sample buffer, incubated for 10 min at
95 °C, and separated for 10 min on a precast 12% (w/v) SDS
acrylamide gel at 100 V. Protein bands were then excised and
sent for mass spectrometric analysis. The same protocol was
followed for the competition experiment (see Fig. 1C). Similarly
to the controls, 1 mM of each nucleotide was added to a protein
mixture of 10 M and preincubated for 1 h before the addition
of the capture compound (10 M).
Protein Purification—E. coli BL21-(DE3) pLysS overexpres-
sion cultureswere inoculated fromovernight cultures in a 1:100
ratio and grown at 37 °C to an OD600 of 0.4, before protein
expression was induced overnight with 0.5 mM isopropyl -D-
thiogalactopyranoside at 18 °C. Cells were then lysed by French
press (3 20,000 p.s.i.) and centrifuged, and the proteins puri-
fied were from the supernatant by nickel-nitrilotriacetic acid
chromatography. 1-ml HiTrap chelating HP columns (Amer-
sham Biosciences) were equilibrated with 10 volumes of wash-
ing buffer (20 mM HEPES, pH 7.5, 250 mM NaCl, 2 mM MgCl2,
and 2.5% (v/v) glycerol, pH 7.5) and loaded with cell lysate.
Following protein immobilization, the column was washed
with 10 volumes of buffer containing 50 mM imidazole, before
proteins were eluted using 500 mM imidazole buffer in a single
step elution.
Differential Radial Capillary of Ligand Assay (DRaCALA)—
The method was performed as described by Roelofs et al. (44).
Purified PleD* (52) was used to synthesize radiolabeled cdG
from [-32P]GTP. The assays were conducted using increasing
concentrations of purified FliI proteins mixed with 4 nM radio-
labeled cdG in each case. Samples were incubated for 2 min at
room temperature with [-32P]cdG in reaction buffer (25 mM
Tris, 250 mM NaCl, 10 mM MgCl2, 5 mM -mercaptoethanol,
pH 7.5). 5 l of each sample were then spotted on nitrocellu-
lose, samples were dried, and results were visualized using a
PhosphorImager screen. In some cases 2-Fluo-AHC-c-diGMP
was used (BioLog 009) as an alternative to [-32P]cdG, at a con-
centration of 0.6M.The resultswere visualized using a charge-
coupled device camera. For the competition experiments, 1mM
of each nucleotide was mixed with 10 M of FliI1–18 and incu-
bated for 30 min before the addition of the fluorescent cdG.
Surface Plasmon Resonance (SPR)—SPR experiments were
conducted at 25 °Cwith a BiacoreT200 system (GEHealthcare)
using a streptavidin SA sensor chip (GEHealthcare), which has
four flow cells each containing SA preimmobilized to a car-
boxymethylated dextran matrix. Flow cells 1 and 3 were kept
TABLE 2
Primers
Name Gene Target Modification Sequence (53 3)
A PFLU4436 (fliI) None TTACTTCATATGCGCCTTGATCGCACCAG
B PFLU4436 (fliI) None ATATTCAATTGTTAGCCGCCCGGCGCG
C PFLU4436 (fliI) 1–18 TTACTTCATATGACATCGTTGCCCGGCCAG
D PSPTO1961 (fliI) None TTACTTCATATGCGCCTTGATCGCGTGAG
E PSPTO1961 (fliI) None AATATCAATTGTCAGCCGCCAGGGG
F STY2180 (fliI) None TTACTTCATATGACCACGCGCCTGACC
G STY2180 (fliI) None AATTGAGAATTCTCACACCGTCGGGAAAAT
H SMc03025 (fliI) None TTACTTCATATGGCACGCGAAGCCGCTG
I SMc03026 (fliI) None AATATCAATTGTCATCCCCTTCCGCGCA
J PSPTO1400 (hrcN) None TTACTTCATATGAACGCCGCACTGAACCAG
K PSPTO1400 (hrcN) None AATATGAATTCTTACTCCGGCAGTTGCGAG
L PFLU6025 (clpB2) None TTACTTCATATGGGTGAAATCAGTCGC
M PFLU6025 (clpB2) None AATATCAATTGTCAATCTGCGTCGC
N PFLU4436 (fliI) G176A CCTGTTCGCCGCTACCGGCGTGG
O PFLU4436 (fliI) G176A CCACGCCGGTAGCGGCGAACAGG
P PFLU4436 (fliI) K181A CGGCGTGGGTGCGTCGGTGTTGC
Q PFLU4436 (fliI) K181A GCAACACCGACGCACCCACGCCG
R PFLU4436 (fliI) D265A GTTGCTGATGGCCTCGCTCACGC
S PFLU4436 (fliI) D265A GCGTGAGCGAGGCCATCAGCAAC
T PSPTO1400 (hrcN) K181A GCGGCAAGGCCACGCTGATG
U PSPTO1400 (hrcN) K181A CATCAGCGTGGCCTTGCCGC
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blank to use for reference subtraction. The chip was first
washed three times with 1 MNaCl, 50mMNaOH to remove any
unconjugated streptavidin. 100 nM biotinylated cdG (BioLog
B098) was immobilized on flow cells 2 and 4 of the streptavidin
chip at a 50-response unit immobilization level with a flow rate
of 5 l/min. Soluble proteins at the required concentrations
were prepared in SPR buffer (10 mM HEPES, 150 mM NaCl,
0.1% (v/v) Tween 20, 2 mM MgCl2) by adjusting the pH for the
different proteins. For FliIHis, FliIHismutants,HrcNHis,HrcNHis
mutants, and ClpB2, the optimal pH was 6.5, whereas for
FliISeT, the optimal pH was 7.5, and for FliI1–18 it was 5.5.
Samples were injected with a flow rate of 5 l/min over the
reference and cdG cells for either 60, 90, or 120 s depending on
their saturation level followed by buffer flow for either 60 or
90 s. The chip was washed at the end of each cycle with 1 M
NaCl. Replicates for each protein concentration were included
as appropriate. In certain cases (e.g. FliISeT), protein precipita-
tion at higher concentrations prevented the acquisition of a
saturated binding curve. In these cases, a representative data set
is presented from at least three independent repetitions. All
sensorgrams were analyzed using Biacore T200 BiaEvaluation
software version 1.0 (GE Healthcare). The data were then plot-
ted using Microsoft Excel and GraphPad Prism.
Linked Pyruvate Kinase/Lactate Dehydrogenase ATPase
Activity Assay—ATPase activity was measured indirectly by
monitoring NADH oxidation. The reaction buffer consisted of
50 mM Tris-Cl, pH 8.0, 2 mM MgCl2, 1 mM DTT, and 10 mM
KCl. Each reaction contained 5mMNADH in 10mMNaOH, 80
mM phosphoenolpyruvic acid, 1.5 l of pyruvate kinase/lactate
dehydrogenase (Sigma), and appropriate concentrations of FliI/
HrcN and cdG and was initiated by the addition of ATP.
Enzyme kinetics were determined by measuring A340 at 1-min
intervals. Kinetic parameters were calculated by plotting the
specific activity of the enzyme (nmol of ATP hydrolyzed/
min/mg of protein) versusATP concentration and by fitting the
nonlinear enzyme kinetics model (Hill equation) in GraphPad
Prism.
Mass Spectrometry of Cross-linked FliI—10MFliIHis protein
was incubated with 10 M cdG capture compound (Caprotec)
and cross-linked in a UV Stratalinker on ice for 4 min. Cross-
linked sample was then separated from non-cross-linked using
magnetic beads as described for the capture compound screen
(above). Cross-linked FliI-cdG and a non-cross-linked control
sample were then run into an SDS gel, and FliI bands were
excised for protein identification. Samples were analyzed by
Nano-LC-MS/MS on an Orbitrap FusionTM TribridTM mass
spectrometer coupled to anUltiMate 3000 RSLCnano LC sys-
tem (Thermo Scientific, Hemel Hempstead, UK). The sample
was separated on aPepMapTM100C18LCColumn (C18, 2m,
500 0.75mm; Thermo) using a gradient of 0.75% (v/v) min1
acetonitrile from 6% to 40% (v/v) in water, 0.1% (v/v) formic
acid at a flow rate of 0.3 l min1 and infused directly into the
mass spectrometer. The mass spectrometer was run in positive
ion mode, with no quad isolation, at 120K resolution over the
mass range 350–1800 (m/z) for the precursor scans (Orbitrap).
One microscan of 50 ms with an AGC target of 2e5 was used.
MS2 threshold was set to 1.5e4, and precursors were frag-
mented by both CID and HCD with CE 	 30 and an isolation
window of 1.6 Da (quadrupole) using the automatic maximum
speed option with ion injection for all available parallelizable
time. Dynamic exclusion was set to 1 count and 30 s. Recali-
brated peaklists were generated using MaxQuant 1.5.2.8, and
the database search was performed with the merged HCD and
CID peaklists using Mascot 2.4 (Matrixscience, London, UK).
The search was performed with a precursor tolerance of 6 ppm
and a fragment tolerance of 0.6 Da on a partial E. coli database,
to which the expected FliIHis protein sequence was added. The
enzyme was set to trypsin/P with a maximum of two allowed
missed cleavages. Carbamidomethyl (C) was set as fixed modi-
fication, and oxidation (M) and acetylation (Protein N-term)
were used as variable modifications. TheMascot search results
were imported into Scaffold 4.4.1.1 using identification proba-
bilities of 99 and 95% for proteins and peptides.
Homology Model Production—A homology model of a
P. fluorescens FliI monomer was created by the Phyre2 server
(53) using the crystal structure of FliI from Salmonella enterica
as a template (Protein Data Bank accession code 2DPY; 63%
amino acid sequence identity) (54). FliI is predicted to be struc-
turally homologous to the  and  subunits of F1-ATPase, and
the latter forms a hexameric ring of alternating  and  sub-
units around a single copy of a  subunit. Using the secondary
structure matching algorithm (55) within the program COOT
(56), amodel of a FliI hexamerwas generated by superposing six
copies of themonomer onto each of the  and  subunits of the
bovine F1-ATPase 33 complex (Protein Data Bank acces-
sion code 2JIZ) (57). All structural figures were prepared using
CCP4 mg (58).
Mass Spectrometry-Peak Shift Analysis (MS-PSA)—MS-PSA
analysis of the sample containing the treated protein FliIHis (i.e.
cross-linked to cdG) was performed as described previously
(44). We further improved the method to specifically search for
spectra relations (i.e. modified versus unmodified peptide)
between spectra from two different samples. Accordingly, we
found many related peptides between the pure (untreated) FliIHis
sample and the treated sample (FliIHis cross-linked to cdG), par-
ticularly for the peptideNVLLLMDSLTR.The followingMS-PSA
parameters were used for both analyses: num 	 8 pmr 	 0.001
t1	 5 t2	 100 fmr	 0.5 mnds	 2 clusterq	 True signif	 1
tol 	 1 outl 	 0.1 nmfp 	 20 mofp 	 9 mnspg 	 2 csf 	 2
peakfreq	 2 nummods	 1 pwss	 4 cp	 3 qual1	 0.2 qual2	
0.2 qual1pl2	 0.5mrms	 150maxdev	 1.MS-PSAparameters
are defined in Fig. S1 of Ref. 44.
Results
The Flagellar ATPase FliI Binds Specifically to cdG—As part
of our ongoing efforts to define the cdG regulon of P. fluore-
scens SBW25, we carried out a series of screening experiments
for cdG binding proteins using a cdG capture compound assay
(45) (Caprotec). These experiments identified homologs of
confirmed binding proteins, including FleQ (23) and WspR
(59), as well as several uncharacterized PilZ, GGDEF, and EAL
domains and numerous proteins for which no previous exper-
imental or predicted link to cdG signaling had been made.
Among these previously unidentified cdG targets, the flagellar
export protein FliI was identified in screens conducted under a
number of different experimental conditions (Kings B medium
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log phase, lysogenic broth stationary phase, andM9 pyruvate
casamino acids). In addition to the suppression of flagellar gene
expression (23) and flagellum rotation (29, 60), FliI-cdG
binding suggests a central, previously unsuspected role for
cdG in the regulation of flagellum protein export and assem-
bly. Consequently, we selected FliI for further biochemical
analysis. First, to confirm that SBW25 FliI binds to cdG in vitro,
the full-length, His-tagged protein (FliIHis) was purified (Fig.
1A), and nucleotide binding was tested using the DRaCALA
binding assay (44). FliIHis bound strongly to 32PcdG but did not
bind to 32PGTP even at far higher protein concentrations (Fig.
1B). To further test the specificity of FliI-cdG binding, compet-
itive DRaCALA and capture compound experiments were per-
formed (Fig. 1C). A variety of nucleotides (cyclic di-GMP, ADP,
ATP, NADH, cAMP, cGMP, and cyclic di-AMP) were added in
excess to compete the 2-Fluo-AHC-c-diGMP and capture
compound, respectively. In both experiments, binding was
abolished only with the addition of cdG, strongly suggesting
that cdG binding by FliI is specific. Our initial attempts to
define the biochemical parameters of cdG binding to FliIHis
used isothermal titration calorimetry. This technique showed
tight, concentration-dependent cdG binding with a KD of
10
M (data not shown). However, we were unable to refine the
isothermal titration calorimetry protocol sufficiently to pro-
duce publishable data. Consequently, we turned to SPR to
examine FliIHis binding to biotinylated cdG. In this experiment,
FliIHis bound to the cdG chip in a concentration-dependent
manner with aKD of 2.4 0.2M (Fig. 2,A and B, and Table 3).
Much of the structural and functional analysis of FliI to date
has been conducted in S. enterica, whose purified FliI homolog
is unstable in vitro unless the N terminus of the protein is trun-
cated (61). This modification affects FliI multimerization, with
the truncated allele unable to form hexameric complexes in
vitro (62). To examine the effects of removing the FliI N termi-
nus on protein-ligand interactions, a truncated FliI allele miss-
ing the first 18 residues (FliI1–18) was purified and analyzed
alongside full-length FliIHis. The FliI1–18 allele bound tightly
and specifically to cdG in both DRaCALA and SPR experi-
ments, with a dissociation constant of 0.75 0.03 M (Figs. 1B
and 2,C andD). The binding constants for both full-length and
truncated FliI fall comfortably within the affinity range of pre-
viously characterized cdG binding proteins (between the low
nanomolar range and 10–15 M (63)), indicating that FliI-cdG
binding is likely to occur in P. fluorescens under physiologically
relevant conditions.
FliI Homologs from Diverse Bacterial Species and the Export
ATPases of Type III and Type VI Secretion Systems Bind cdG
at Physiological Concentrations—Flagella-driven motility, and
hence FliI-mediated export, is ubiquitous among Gram-nega-
tive bacteria. To investigate whether cdG-binding to FliI is sim-
ilarly widespread, full-length FliI homologs from several bacte-
rial species were cloned, expressed, purified, and then tested for
cdG binding using SPR. FliI homologs were selected from
human and plant pathogens, as well as commensal and symbi-
otic plant growth-promoting organisms. The tested FliI homo-
logs included representatives from the- and-proteobacterial
classes and both monotrichous and polyflagellated bacteria.
Concentration-dependent cdG binding was detected for full-
length FliI alleles from the phytopathogen P. syringae pv.
tomato (Pto) DC3000 (FliIPto), the human pathogen S. enterica
serovar typhimurium (FliISeT), and the nitrogen-fixing symbi-
ont Sinorhizobiummeliloti (FliISm) (Fig. 3 andTable 3). Despite
a reasonably high degree of fliI amino acid sequence divergence
(SBW25 and S. meliloti fliI share only 35.4% identity) and sig-
nificant differences in flagella regulation and cdG signaling
between the tested species, all four FliI homologs bound to the
dinucleotide molecule with affinities well within the expected
physiological range of intracellular cdG concentrations.
The export apparatus of the bacterial flagellum is closely
related to that of the T3SS, with both complexes sharing a com-
mon ancestor (8). Furthermore, cdG has been associated with
the control of T3SS function in the opportunistic pathogen
Pseudomonas aeruginosa (64, 65), although the mechanism of
this regulation is currently unclear. In light of this, our data for
FliI-cdG binding implicate the T3SS export ATPase HrcN as a
further potential cdG-binding target. To test this, we purified
the full-length, His-tagged protein from PtoDC3000 (HrcNHis)
and examined cdG binding using SPR. As predicted, HrcNHis
FIGURE 1. A, Coomassie-stained SDS-PAGE gel showing purified FliIHis frac-
tions eluted with 500 mM imidazole. B, DRaCALA for [32P]cdG and [32P]GTP
binding to increasing concentrations of full-length FliI (FliIHis). Positive (10M
PleD*) and negative (10 M BSA) binding controls are included, as well as
N-terminal truncated FliI (10 M FliI1–18). C, DRaCALA competition experi-
ment performed on FliI1–18. A variety of nucleotides were included in the
reaction to test the specificity of cdG binding. SDS-PAGE gel showing protein
bound to the capture compound after preincubation with different
nucleotides.
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also bound strongly to cdG, with a dissociation constant of
3.2  0.2 M (Fig. 4, A and B). The type VI secretion system
export ATPase (ClpB2) is far more distantly related to FliI, in
terms of both primary sequence and organization of the
ATPase subunits within the type VI secretion complex (66).
Nonetheless, as ClpB2 is a rotary ATPase and type VI secretion
is known to be under reciprocal, cdG-linked control with type
III secretion (65), full-length ClpB2 (ClpB2His) was purified and
tested for cdG binding. To our surprise, ClpB2 also displayed
strong, concentration-dependent binding to the cdG with a
physiologically relevant binding affinity of 9.5 0.5 M (Fig. 4,
C and D). These data strongly suggest that binding to the cdG
second messenger is a widespread characteristic across diverse
rotary ATPase export proteins.
Addition of cdG Inhibits FliI andHrcNATPaseActivity—The
established model for cdG function associates increased dinu-
cleotide levels with reduced motility and virulence (22). This
has been shown to be the case for both P. fluorescens (67) and
P. syringae (17, 18, 21). Consequently, we hypothesized that
cdG binding may negatively affect the ATP-dependent export
activity of FliI and/or HrcN. To examine the effect of cdG bind-
ing on FliI/HrcN ATPase activity, pyruvate kinase/lactate de-
hydrogenase-linked ATPase activity assays were conducted for
the full-length protein alleles FliIHis and HrcNHis. Purified
FliIHismetabolizedATPwith aKm of 0.48 0.03Mand aVmax
of 1262 54.46 nmATP/min/mg.Addition of 50McdG led to
a noticeable drop in Vmax, to 867.2  51.65 nm ATP/min/mg
(Fig. 5A). The IC50 of cdG for FliIHis (36.7 1.13 M) was then
determined by increasing cdG levels while maintaining a con-
stant ATP concentration in the reaction (Fig. 5B). Similar cdG
FIGURE 2. A, SPR sensorgrams showing affinity measurements for FliIHis binding to biotinylated cdG. A range of FliIHis concentrations was used (0.312, 0.625,
1.25, 2.5, 5, 10, 20, and 40M), and concentration replicates were included as appropriate together with buffer only and BSA controls. The protein binding and
dissociationphases for all sensorgrams are shown.B, affinity fit for FliIHis-cdGbinding. Thebinding response for each concentrationwas recorded4 sbefore the
end of the injection, and the KD values for FliIHis binding to cdG (2.4 0.2 M) were calculated using the BiaEvaluation software and confirmed by GraphPad
Prism. C, SPR sensorgrams showing affinity measurements for FliI1–18 binding to biotinylated cdG. A range of protein concentrations was used (0.078, 0.156,
0.3125, 0.625, 1.25, 2.5, 5, and 10 M), and concentration replicates were included as appropriate together with buffer only and BSA controls. The protein
binding and dissociation phases for all sensorgrams are shown.D, affinity fit for FliI1–18-cdG binding. Binding responses weremeasured 4 s before the end of
the injection, and the KD values for FliI1–18 binding to cdG (0.8 0.03M)were calculatedusing the BiaEvaluation software and confirmedbyGraphPadPrism.
TABLE 3
Binding affinity data for tested FliI, HrcN, and ClpB2 variants
Dissociation constant (KD) values for the ATPase proteins analyzed in this study are
shown. Binding to FliISeT was concentration-dependent but did not saturate in the
kinetic experiment.
KD
M
FliIHis (full-length) 2.4 0.2
FliI1–18 (N-terminally truncated) 0.8 0.03
FliI1–18 R170H Not determined
FliI1–18 E208Q Not determined
FliI1–18 R337H Not determined
FliIPto (Pto DC3000) 7.6 0.8
FliISeT (S. enterica) Not determined
FliISm (S. meliloti) 3.2 0.7
HrcNHis 3.2 0.2
ClpB2His 9.5 0.5
FliI G176A (Walker A mutant) 11.0 1.1
FliI K181A (Walker A mutant) 2.2 0.2
HrcN K181A (Walker A mutant) 3.8 0.4
FliI D265A (Walker B mutant) 4.5 0.2
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inhibitory activity was seen for FliI1–18, which metabolized
ATP with Km and Vmax values of 0.45  0.04 M and 691.5 
41.90 nm ATP/min/mg without cdG. Upon addition of 50 M
of the dinucleotide molecule, Vmax dropped to 375.4  35.34
nm ATP/min/mg. FliI1–18 has an IC50 value of 48.8  0.159
M. In agreement with DRaCALA results seen for FliIHis (Fig.
1B), addition of GTP produced no change in ATPase activity,
supporting a specific inhibitory role for cdG toward FliI ATPase
activity (data not shown). Full-length HrcN showed a similar
degree of ATPase inhibition to FliI, with Vmax dropping from
1183 68.2 to 832.4 119.7 nm ATP/min/mg upon addition
of 50M cdG, with an IC50 of 25.11 1.14M (Fig. 5,C andD).
Addition of GTP had no effect onHrcNHis ATPase activity (Fig.
5D), arguing once again for specific cdG inhibition of HrcN
ATPase activity.
ATPase Activity and cdG Binding Are Uncoupled by Muta-
tions in the FliI/HrcN Walker A and B Motifs—To further
examine the relationship between ATP hydrolysis and cdG
binding for FliI and HrcN, a series of full-length alleles were
producedwith residue substitutions in the conservedWalker A
and Walker B motifs (68, 69) of the ATPase active site. The
variant proteins were then purified and subjected to SPR anal-
ysis andATPase activity assays as described above. Substitution
of the critical FliI Walker A lysine residue for alanine (K181A)
had very little effect on cdG binding affinity (Fig. 6A and Table
3) but entirely abolished ATPase activity (Fig. 6B). Conversely,
substitution of the first conserved Walker A glycine to alanine
(G176A) led to a mild reduction in FliI ATPase activity but
almost entirely abolished the ability of the protein to bind cdG.
Finally, a Walker B motif (D265A) substitution in FliI resulted
in the complete abolition ofATPase activity but only a relatively
small drop in the cdG binding affinity of the protein (Fig. 6, A
andB, andTable 3). This is consistent with our previous results,
which show that neither ATP nor ADP have any effect on cdG
binding when included in DRaCALA assays (Fig. 1C). These
results indicate that cdG binding and ATPase activity may be
uncoupled.
Identifying the Site of cdG Capture Compound Binding in
FliI—To further investigate the site of cdG binding on FliI, we
constructed a homology model for SBW25 FliI based on the
crystal structure of its Salmonella homolog (54) (Fig. 7). The
location of ATP and the conserved residues across the six cdG-
binding ATPases in this study were then mapped onto the
model, and a predicted FliI hexameric complex was produced
(Fig. 7A). Next, purified FliIHis was incubated and UV cross-
linked to the cdG capture compound. Following tryptic diges-
tion and mass spectrometry, mass-shifted peptides were iden-
tified using MS-PSA, a recently developed analysis method for
the identification of unexpected/unknown peptide modifica-
tions (70) (supplemental Fig. S1). Two MS-PSA analyses were
performed, treated (i.e. cross-linked to cdG) versus untreated
FliIHis (S1A) and treated FliIHis alone (S1B). In the treated sam-
ple, we expected to identify both pure FliIHis and FliIHis with
bound cdG. Accordingly, many spectra relations correspond-
FIGURE 3. A and B, SPR sensorgrams and resulting affinity fit for FliIPto binding to biotinylated cdG. C and D, SPR sensorgrams and affinity fit for FliISeT binding
to biotinylated cdG. E and F, SPR sensorgrams and affinity fit for FliISm binding to biotinylated cdG. In all three cases, a rangeof protein concentrationswas used
(0.625, 1.25, 2.5, 5, 10, and for FliIPto/FliISeT 20M), and concentration replicates were included as appropriate together with buffer only and BSA controls. The
protein binding and dissociation phases for all sensorgrams are shown. For the affinity fits, binding responses were measured 4 s before the end of the
injection, and KD values for each protein were calculated using the BiaEvaluation software and confirmed by GraphPad Prism (Table 3).
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ing to modified and unmodified peptides were identified (sup-
plemental Fig. S1). Importantly, the most densely modified
peptide following cdG capture compound cross-linking com-
prised residues 259–269 (NVLLLMDSLTR; supplemental Fig.
S1).We identified 36 spectra relationswhere the lighter peptide
was Mascot annotated NVLLLMDSLTR, and the heavier not-
annotated partner carried a modification of 150 Da. By only
comparing spectra between the treated and untreated sample,
we identified 52 corresponding NVLLLMDSLTR spectra rela-
tions. The NVLLLMDSLTR peptide represents the central
strand of a -sheet at the core of the SBW25 FliI homology
model, plus short loops at either end (Fig. 7B, green). The C
terminus of the -strand also contains the conserved aspartate
(Asp-265) of the Walker B motif (Fig. 7B, pink). Interestingly,
the end of the capture compound cross-linked peptide emerges
close to a cluster of highly conserved residues that could form a
pocket at the interface between two FliI subunits in our model
(Fig. 7, C and D, red). As well as several glycine and proline
residues, this conserved pocket contains two arginines (Arg-
170 and Arg-337) from one subunit and a glutamate (Glu-208)
from the second. Both arginine and glutamate are highly impor-
tant for dinucleotide binding in all previously characterized
cdG binding proteins (40, 42).
To confirm the importance of these residues to cdG binding,
specific amino acid substitutions were produced (R170H,
E208Q, and R337H) in FliI1–18. The solubility of the resulting
FliI1–18 alleles was confirmed by gel filtration (data not
shown), and then cdG binding andATPase activity were tested.
All three substitutions showed seriously compromised cdG
binding, with KD values that were too high to be accurately
determined (Fig. 8A and Table 3) and a complete abolition of
ATPase activity (Fig. 8B). Finally, we detected no cdG binding
for the hexameric ATPase protein NtrC from Azotobacter
vinelandii, which shares a tertiary structure foldwith the export
ATPases but does not have the residues of the proposed binding
site (Fig. 8C). Together, these results strongly indicate that the
binding indeed occurs at the proposed site shown in Fig. 7D.
Discussion
Here we show that the second messenger cdG binds to the
bacterial flagellum export ATPase FliI. This cyclic dinucleotide
binding is apparently widespread, with FliI homologs from
multiple different bacterial species showing strong, con-
centration-dependent binding activity upon the addition of
cdG. Excitingly, cdG binding at physiologically relevant (low
micromolar) affinities was also determined for the closely
related type III secretion exporter HrcN from Pto DC3000 and
the muchmore distantly related P. fluorescensType VI ATPase
ClpB2. Our findings implicate cdG in the direct, allosteric reg-
ulation of both flagellar protein export and type III/typeVI-me-
diated virulence for a range of pathogenic, commensal, and
beneficial bacterial species.
FIGURE 4.A and B, SPR sensorgramand resulting affinity fit for HrcN (type III export ATPase) binding to biotinylated cdG.C andD, SPR sensorgramand resulting
affinity fit for ClpB2 (Type VI export ATPase) binding to biotinylated cdG. In both cases, a range of protein concentrations was used (0.625, 1.25, 2.5, 5, and 10
M), and concentration replicateswere included as appropriate togetherwith buffer only and BSA controls. The protein binding anddissociation phases for all
sensorgrams are shown. For the affinity fits, binding responses were measured 4 s before the end of the injection, and KD values for each protein were
calculated using the BiaEvaluation software and confirmed by GraphPad (Table 3).
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The ATPase activity of both FliI and HrcN is suppressed by
the addition of cdG. In this respect, the relationship between
cdG and the export ATPase proteins is reminiscent of the tran-
scriptional motility regulators FleQ (27) and FlrA (71). These
proteins both contain AAA ATPase domains and bind cdG
close to the Walker A motif of the protein. However, there
appear to be important differences between the binding char-
acteristics of FleQ/FlrA and the export ATPase proteins
described here. In FleQ, cdG interacts with theWalker A site of
the protein, leading to competitive inhibition of ATPase activ-
ity (27). Similarly, cdG binding to an arginine residue (Arg-176)
downstream of theWalker A motif of FlrA inhibits binding to its
target promoter sequence (71). In the case of the export ATPase
proteins, we were able to uncouple ATPase activity from cdG
binding. Our FliI/HrcN K181A mutants bound strongly to cdG
but displayed no ATPase activity, whereas the G176A mutant
retained substantialATPase activity but showed severely compro-
mised cdG binding. Furthermore, the FlrA R176 residue is con-
served in FleQ but not in FliI/HrcN/ClpB2 (Fig. 9, purple), again
suggesting a distinct cdG bindingmechanism.
FIGURE5.A, ATPaseactivity for FliIHis50McdG. FliIHis specific activity (nmolATPhydrolyzed/min/mgprotein) is shown for increasingATPconcentrations.Addition
of cdG causes a decrease of the Vmax of FliIHis ATPase activity. B, IC50 curve for FliIHis ATPase activity upon addition of increasing cdG concentrations. A constant
concentration of ATP (1 mM) was included alongside 1 g of FliIHis protein. C and D, ATPase activity 50 M cdG, and IC50 curve upon addition of increasing cdG
concentrations, for HrcN. All parameters remain the same as inA. The IC50 curve also includes results for GTP titration showing noATPase inhibition.
FIGURE6.A, affinity fit for cdGbinding todifferentFliI alleles (FliIHis,1–18,K181A,D265A, andG176A). SensorgramsobtainedusingbiotinylatedcdG (Figs. 1Dand2B)
wereused to calculate theKD values for FliI binding to cdG (Table 3). At eachprotein concentration, the responseswere recorded4 sbefore theendof the injection.B,
ATPase activity for different FliI alleles. Protein specific activity in each case (nmol ATP hydrolyzed/min/mgprotein) is shown for increasing ATP concentrations.
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Based on our biochemical and mutagenesis data for FliI/
HrcN,mass spectrometric analysis of cdG cross-linked FliI, and
in silicomodeling of hexameric FliI, we identified an intriguing
potential site for cdG binding to the rotary export ATPases.
This site, at the interface between two protein monomers, con-
tains highly conserved glutamate and arginine residues known
to be required for cdG binding (42). The putative binding
pocket also contains both a proline and two glycines, whichmay
play a role in maintaining the structure of the binding pocket.
Mutagenesis and subsequent in vitro binding tests confirmed
that the conserved glutamate and arginine residueswere indeed
required for cdG binding. Although loss of binding was accom-
FIGURE 7. A, homologymodel of the predicted hexameric formof SBW25 FliI, based on the crystal structure of FliI from S. typhimurium (Protein Data Bank code
2DPY). Conserved residues between the six cdG-binding proteins tested in this study aremarked in red (on the gray and cyan-colored subunits only), and ADP
(stickmodel; taken from template structure) is shownbound at the interfaces between the individual FliI subunits. B, close-up of the interface between two FliI
subunits, showing theNVLLLMDSLTR peptide implicated in cdG capture compound binding (circled, in green) and the conservedWalker B aspartate (Asp-265)
in pink. C, locations of conserved residues between the six cdG-binding proteins tested in this study (red). D, close-up of the proposed cdG binding pocket
(circled). Conserved residues suggested to form the cdG binding site are labeled.
FIGURE 8. A, affinity fit for cdG binding to different FliI alleles (FliI1–18, FliI1–18 R170H, FliI1–18 E208Q, and FliI1–18 R337H). B, ATPase activity for different FliI
alleles. Protein specific activity in each case (nmol ATP hydrolyzed/min/mg protein) is shown for increasing ATP concentrations. C, DRaCALA binding assay for
[32P]cdG to 10 M NtrC (A. vinelandii). Positive (10 M BldD*) and negative binding controls (NC) were included as appropriate.
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panied by loss of ATPase activity in each case, this result is
perhaps unsurprising given that the mutations made were at
the FliI dimerization interface. Structural determination of FliI
and HrcN in complex with cdG is underway and should allow
us to determine exactly where and how cdG interacts with
export ATPase complexes.
In general, cdG represses the production and function of fla-
gella and type III secretion systems and promotes typeVI secre-
tion, although the relationship between cdG and these different
pathways in Pseudomonas sp. is both highly complex and not
fully understood. Flagella gene expression in Pseudomonas sp.
is controlled by cdG through FleQ, which binds to numerous
flagellar loci and whose inactivation by cdG binding (or dele-
tion) abolishes flagella production (23). Flagella rotation is also
likely to be under cdG control in P. fluorescens and P. syringae,
because both contain close homologs to the P. putida rotation
controller FlgZ (28). cdG has also been shown to control
swarming motility in P. aeruginosa by switching between two
different stator complexes; MotAB and MotCD (60). Other
cdG-regulated pathways, such as pili synthesis (37) and exopo-
lysaccharide production (23, 72) also have indirect impacts on
both flagella deployment and motility (73, 74).
cdG is also known to control the level/activity of the
P. aeruginosa type III and type VI secretion systems (64, 65),
although here the regulatory pathways are less well understood.
Moscoso et al. (65) show that cdG mediates the switch between
productionof type III and typeVI secretionpathways and that this
switch requires the sRNAsRsmYandRsmZ, linking cdGsignaling
to the small translational regulatory protein RsmA. Translation of
both flagella and type III mRNAs are controlled by RsmA in
P. aeruginosa (75), which is itself involved in a complex regulatory
network involving downstream cdG signaling (76, 77). A role for
cdG in the allosteric suppression of FliI/HrcN export in vivo is
entirely consistent with the wider literature for both flagellar
motility and type III secretion. Certainly, our biochemical data
strongly suggest that increased intracellular cdG levelswould sup-
press theATPaseactivity andhencemightbeexpected to suppress
the export activity of these proteins. However, whether suppres-
sion of ATPase activity represents the actual in vivo function of
export ATPase-cdG binding is currently uncertain.
FIGURE 9. Clustal alignment of conserved residues between FliI, HrcN, and ClpB2 proteins in this study. Identities between all six residues are marked
with asterisks (*), and similarities across all six with periods (.) or colons (:). The mutated FliI Walker A/B residues (see Fig. 6) are marked in red, the capture
compound-bindingNVLLLMDSLTR peptide ismarked in blue, the position of the conserved cdG binding arginine in FlrA (Arg-176) ismarked in purple, and the
conserved residues of the proposed cdG binding site are marked in green (see Fig. 7).
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Recently, Minamino et al. (14) showed that only residual FliI
ATPase activity is actually required for flagellum production in
Salmonella, with the majority of the energy for protein export
provided by the protonmotive force. FliI ATPase activity is still
required for effective export to occur but is thought to play a
gatekeeper role, where it provides the basal body with the
energy required to initiate protein export (13, 14). If, as
Minamino et al. suggest, reduced FliI ATPase activity upon cdG
binding does not necessarily translate into reduced flagellar
protein export, then what else might be the role of cdG? Our
results show that cyclic dinucleotide binding is both wide-
spread and highly conserved among export ATPases. Further-
more, the binding affinities we observed for cdG are sufficiently
high that dinucleotide binding should occur frequently under
“normal” environmental conditions.
We propose that FliI-cdG bindingmay play amore fundamen-
tal role in controlling flagella function and assembly. Specifically, a
basal level of FliI-cdGbindingmay be required for the initiation of
FliI export, via the promotion of multimerization, imposition of
rotational asymmetry to the FliI hexamer (78) or another unde-
finedmechanism. In support of this hypothesis, basal levels of cdG
have been shown to be required for flagella synthesis in both
S. enterica (79) and Caulobacter crescentus (80). In both cases,
deletion of all GGDEF domain-containing proteins, and hence
cdG, from the cell resulted in a loss of flagella-driven motility. In
Salmonella, cdG removal led to increased expression of flagella
basal body genes, but a severe defect in the export of FliC (79).
Similarly for C. crescentus, the production of basal body proteins
wasunaffectedby cdGremoval,whereas class III and class IVgene
expression was severely reduced (80). In this case, the reduced
flagella gene expression could be explained by anti- factor-in-
duced feedback upon the loss of flagellar export (81). Whether
such amechanism also applies to the ATPases of type III and type
VI systems is unclear at this stage. Although the cdG-null strain of
S. enterica showed a loss of virulence consistent with loss of T3SS
function (79), more evidence is required to confidently propose a
model for the relationship between cdG and HrcN/ClpB2 func-
tion. Research is ongoing to determine the exact nature of the
relationship between cdG and the rotaryATPase proteins and the
impact of cdG-ATPase binding on motility and virulence in bac-
terial species.
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